GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PetVivo Holdings Inc (OTCPK:PETV) » Definitions » Shiller PE Ratio

PetVivo Holdings (PetVivo Holdings) Shiller PE Ratio : (As of May. 21, 2024)


View and export this data going back to 2012. Start your Free Trial

What is PetVivo Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


PetVivo Holdings Shiller PE Ratio Historical Data

The historical data trend for PetVivo Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetVivo Holdings Shiller PE Ratio Chart

PetVivo Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PetVivo Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PetVivo Holdings's Shiller PE Ratio

For the Medical Devices subindustry, PetVivo Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PetVivo Holdings's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PetVivo Holdings's Shiller PE Ratio falls into.



PetVivo Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

PetVivo Holdings's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, PetVivo Holdings's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.12/129.4194*129.4194
=-0.120

Current CPI (Dec. 2023) = 129.4194.

PetVivo Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.000 99.695 0.000
201406 -0.533 100.560 -0.686
201409 -0.533 100.428 -0.687
201412 -0.533 99.070 -0.696
201503 -0.311 99.621 -0.404
201506 -0.800 100.684 -1.028
201509 -0.267 100.392 -0.344
201512 -0.222 99.792 -0.288
201603 -0.800 100.470 -1.031
201606 -0.178 101.688 -0.227
201609 -7.111 101.861 -9.035
201612 -0.133 101.863 -0.169
201703 -0.222 102.862 -0.279
201706 -0.133 103.349 -0.167
201709 -0.089 104.136 -0.111
201712 -0.133 104.011 -0.165
201803 -0.267 105.290 -0.328
201806 -0.489 106.317 -0.595
201809 -0.178 106.507 -0.216
201812 -0.120 105.998 -0.147
201903 -0.280 107.251 -0.338
201906 -0.120 108.070 -0.144
201909 -0.120 108.329 -0.143
201912 -0.100 108.420 -0.119
202003 -0.090 108.902 -0.107
202006 -0.160 108.767 -0.190
202009 -0.230 109.815 -0.271
202012 -0.160 109.897 -0.188
202103 -0.040 111.754 -0.046
202106 -0.070 114.631 -0.079
202109 -0.130 115.734 -0.145
202112 -0.170 117.630 -0.187
202203 -0.190 121.301 -0.203
202206 -0.200 125.017 -0.207
202209 -0.210 125.227 -0.217
202212 -0.230 125.222 -0.238
202303 -0.210 127.348 -0.213
202306 -0.250 128.729 -0.251
202309 -0.280 129.860 -0.279
202312 -0.120 129.419 -0.120

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PetVivo Holdings  (OTCPK:PETV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


PetVivo Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of PetVivo Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PetVivo Holdings (PetVivo Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5251 Edina Industrial Boulevard, Edina, MN, USA, 55439
PetVivo Holdings Inc is an emerging biomedical device company. The group is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. A key strategy of the company is to leverage human therapies for the treatment of companion animals cost-effectively and in a timely manner. The accelerated timeline to revenues for veterinary medical devices is a key component of this strategy, which enter the market much earlier than pharmaceuticals and biologics. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of nineteen patents.
Executives
James Rudolph Martin director POBOX 53988, IRVINE CA 92619
A.l. Sarroff Fund, Llc 10 percent owner 43 MEADOW WOODS ROAD, GREAT NECK NY 11020
John Spencer Breithaupt director 3041 W. PASADENA DR., BOISE ID 83705
Robert J Costantino director 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Joseph William Jasper director 201 SOUTH 11TH STREET, UNIT 1030, MINNEAPOLIS MN 55403
John Lai director, 10 percent owner, officer: CEO 12100 SINGLETREE LANE, SUITE 186, EDEN PRAIRIE MN 55344
Robert James Rudelius director 6913 ARBOR LANE, MCCLEAN VA 22101
Leslie Anne Coolidge director 345 OLD SUTTON ROAD, BARRINGTON HILLS IL 60010
Robert J. Folkes officer: Chief Financial Officer 1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Scott Mitchell Johnson director 475 LAKESHORE UNIT #32, INCLINE VILLAGE NV 89451
James Joseph Martin director 4400 BISCAYNE BLVD, SUITE # 670, MIAMI FL 33157
Gregory D Cash director
John Michael Carruth officer: Acting Chief Financial Officer 4923 RIVER WOOD DR., SAVAGE MN 55439
Sherry Grisewood director 377 FAIRMOUNT ROAD, CALIFON NJ 07830
David Don Deming director 16200 45TH STREET SOUTH, AFTON MN 55001